Business
Currency:USD
2017/FY
Stock NameRevenueRatio
Discovery, development and commercialization of novel therapeutics for allergic and immunological500K100.00%
Region
Currency:USD
2017/FY
Stock NameRevenueRatio
United States500K100.00%